Related Experiment Video
Updated: Jan 4, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Left Ventricular Assist Device Infections and the Potential Role for Dalbavancin: A Case Report
Jessica Howard-Anderson1, Stephanie M Pouch1, Mary Elizabeth Sexton1
1Division of Infectious Diseases, Atlanta, Georgia.
Abstract:
Left ventricular assist device infections (LVADIs) are common but challenging to treat, often requiring prolonged courses of intravenous antibiotics. Dalbavancin could have a role in treating patients with chronic LVADIs given its less frequent dosing requirements. Here, we illustrate a case in which dalbavancin was used as suppressive therapy for an LVADI for greater than 7 months.
More Related Videos
11:28A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Endocarditis II: Clinical Features of Infective Endocarditis
Pneumonia III: Complications and Assessment